For the first time, the European Health Summit travels beyond Brussels and lands in Madrid, opening a new space for dialogue at the heart of one of Europe’s most active health policy landscapes.
This high-level convening on rare diseases is the result of a joint effort between the European Health Summit and the Spanish Ministry of Health, reflecting a shared commitment to advancing the conversation on rare diseases at both national and European level.
Building on decades of expertise in EU affairs, event planning and facilitation, EBS develops and implements communication, dissemination, and advocacy strategies for EU-funded projects (e.g., Horizon Europe, Erasmus+) across a wide array of topics.
The overall objective of ERAMET is to provide an integrated approach for developers and regulators’ decision-making for paediatric and orphan drugs, centred on the drug development questions.
NOVATERRA is an EU-funded Horizon 2020 project which aims to maintain current yields and quality in Europe while eliminating or significantly reducing the use of pesticides.
SHERPA is a project that investigates and analyses our understanding of the ways in which Smart Information Systems impact ethics and human rights issues.
Our mission is twofold: we aim to bring politics and business together in order to provide them with an opportunity to debate and pursue their common goals, giving a voice to all sides of the debate. The other priority of EBS is to provide European institutions with a platform where they can place their top priorities in the spotlight and advance the development of new pieces of legislation through discussion with a variety of actors and stakeholders.
